Maribavir is an antiviral active pharmaceutical ingredient used as a cytomegalovirus pUL97 kinase inhibitor. It is a pharmaceutical raw material supplied for the manufacturing of antiviral medications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 176161-24-3
Baloxavir
pharmaceutical raw material
Favipiravir
pharmaceutical raw material
Ensitrelvir fumarate
pharmaceutical raw material
Zanamivir
pharmaceutical raw material
Flurazepam
pharmaceutical raw material
Abametapir
pharmaceutical raw material
Omeprazole-N-oxide
pharmaceutical raw material
Ceruletide
pharmaceutical raw material
(2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol
KJFBVJALEQWJBS-XUXIUFHCSA-N
CC(C)NC1=NC2=CC(=C(C=C2N1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)Cl